LET IN THE LYTE Trademark

Trademark Overview

On Friday, April 29, 2022, a trademark application was filed for LET IN THE LYTE with the United States Patent and Trademark Office. The USPTO has given the LET IN THE LYTE trademark a serial number of 97388270. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Tuesday, October 14, 2025. This trademark is owned by INTRA-CELLULAR THERAPIES, INC.. The LET IN THE LYTE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; Pharmaceutical preparations for the treatment of schizophrenia; Pharmaceutical preparations for the treatment of bipolar disorder
let in the lyte

General Information

Serial Number97388270
Word MarkLET IN THE LYTE
Filing DateFriday, April 29, 2022
Status734 - FIFTH EXTENSION - GRANTED
Status DateTuesday, October 14, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 28, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; Pharmaceutical preparations for the treatment of schizophrenia; Pharmaceutical preparations for the treatment of bipolar disorder
Pseudo MarkLET IN THE LIGHT

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 4, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameINTRA-CELLULAR THERAPIES, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBedminster, NJ 07921
Party NameINTRA-CELLULAR THERAPIES, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10016

Trademark Events

Event DateEvent Description
Tuesday, March 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 3, 2022NEW APPLICATION ENTERED
Wednesday, May 4, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 17, 2023ASSIGNED TO EXAMINER
Wednesday, February 22, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 28, 2023PUBLISHED FOR OPPOSITION
Tuesday, May 23, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, May 24, 2024SOU EXTENSION 3 FILED
Thursday, May 30, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 22, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, November 22, 2023SOU EXTENSION 1 FILED
Wednesday, November 22, 2023SOU EXTENSION 1 GRANTED
Friday, November 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 23, 2024SOU EXTENSION 2 FILED
Thursday, May 23, 2024SOU TEAS EXTENSION RECEIVED
Friday, May 24, 2024SOU EXTENSION 3 GRANTED
Thursday, May 30, 2024SOU EXTENSION 2 GRANTED
Friday, May 31, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 23, 2025SOU EXTENSION 4 FILED
Friday, May 23, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, August 12, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, May 23, 2025SOU EXTENSION 4 GRANTED
Saturday, May 24, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 12, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 12, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 12, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 12, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, October 12, 2025SOU EXTENSION 5 FILED
Monday, October 13, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, October 14, 2025SOU EXTENSION 5 GRANTED
Wednesday, October 15, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

lyte pharmaceutical preparations treatment nervous system central bipolar disorder schizophrenia disorders